您当前的位置:
首页 >
文章列表页 >
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
- MMR 2023年10卷第4期 页码:431-443
DOI: 10.1186/s40779-022-00420-0
移动端阅览
HTML全文
图( 4 ) 表( 3 )
参考文献
出版信息
数据统计
51
浏览量
15
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Engineering of functional auditory neurons from human induced pluripotent stem cells
相关作者
Zhe-Wei Kang
Yun-Dan Liao
Jun Li
Tian-Lan Lu
Hao Yan
Xiao Xiao
Yong-Feng Yang
Wen-Qiang Li
相关机构
Institute of Mental Health, Peking University Sixth Hospital
Chinese Institute for Brain Research
National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital
NHC Key Laboratory of Mental Health and Research Unit of Diagnosis and Treatment of Mood Cognitive Disorder (2018RU006), Chinese Academy of Medical Sciences
Peking University Huilongguan Clinical Medical School, Beijing Huilongguan Hospital

